Zyprexa has been linked to the early onset of diabetes, hyperglycemia, or other diabetes-related complications that can result in coma or death. Researchers identified 289 cases of diabetes in patients who had been given Zyprexa. Of these 289 cases:
- 225 were newly diagnosed diabetic patients
- 100 developed ketosis, a serious diabetes-related complication
- 22 developed pancreatitis, a life-threatening inflammation of the pancreas
- 23 died
- 71% occurred within six months of starting treatment with Zyprexa.